Information about Verzele Pharma
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Verzele Pharma (SRL)

Company information
Status
Active
Enterprise number
BE0896.764.703
VAT liability
Yes
Established
26-03-2008
Last balance sheet year
2023
Company size
Small 2 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Verzele Pharma

{{translate("download")}}

Publications in the Belgian Official Journal from Verzele Pharma

Date Publication
24-01-2024 Modification(s) Articles of Association (NL)
16-11-2017 Designation - Registered Office - Goal - Resignations - Appointments - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
20-04-2011 Designation - Resignations - Appointments (NL)
12-01-2009 Miscellaneous (NL)
09-04-2008 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Verzele Pharma?
The VAT number of Verzele Pharma is BE0896764703.
When was Verzele Pharma founded?
Verzele Pharma was founded on 26-03-2008.
What is the address of Verzele Pharma?
The current registered office of Verzele Pharma is located at Diependale 8, 9700 Oudenaarde.
When was the last time Verzele Pharma filed their annual financial statements?
The most recent financial statements of Verzele Pharma were filed on 16-07-2024. You can view them here.
How many employees does Verzele Pharma have?
There are 2 FTEs working at Verzele Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Verzele Pharma?
At the time of its most recent financial statements, Verzele Pharma did not publish any turnover figures. Verzele Pharma reported a gross margin of €218,748.88.